Israeli scientists are developing a revolutionary treatment for liver disease.
Reported by Joseph Sherman
Nonalcoholic steatohepatitis (NASH) is a “silent” liver disease which affects two to five percent of Americans – approximately six to fifteen million people. Another ten to twenty percent of Americans, thirteen to twenty three million people, have fat in their livers but have not yet developed NASH. Tens of millions of people around the world also are at risk of suffering from NASH.

Dr. Rachamim at NasVax’s lab in Ness Ziona, Israel
The US National Institutes of Health explains: ”It resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. Continue Reading »














Israeli New Shekel Exchange Rate